Tatrtaxhyplesin II alpha2 antibacterial peptide from tachypleus tridentatus as well as preparation method and application of Tatrtaxhyplesin II alpha2 antibacterial peptide
By developing the antibacterial peptide of China's horseshoe horses_tachyplesinII_α2, the problem of uneven effects of existing antibacterial peptides in inhibiting bacteria and tumor cells is solved, and effective inhibition of a variety of aquatic pathogenic bacteria and tumor cells is achieved, and antibiotic resistance and antibacterials are filled. The gap in drug development provides new peptide product applications.
Patent Information
- Application Number
- CN202410904278.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-08
- Publication Date
- 2024-11-15
AI Technical Summary
The existing antimicrobial peptides have uneven effects in inhibiting bacterial growth and inhibiting tumor cells, and the problem of antibiotic resistance is becoming increasingly serious. New antimicrobial drugs are needed to replace traditional antibiotics and enhance antimicrobial peptides.
The Chinese horseshoe horses_tachyplesinII_α2 antibacterial peptide was developed. Its amino acid sequence is MKKFVIALCLMMVLAVMVEDAEARWCFRVCYRGICYRKCRGKRNEVRQYRDRGCDVGAMPDETFFARQDEDEDDDEEE. It was prepared by solid-phase chemical synthesis and high-performance liquid chromatography purification, and has the inhibitory effect on a variety of aquatic pathogenic bacteria and tumor cells.
TaTrs_tachyplesinII_α2 antibacterial peptide has a significant inhibitory effect on aquatic pathogens such as E. coli, Bacillus subtilis, Staphylococcus aureus, and has a good inhibitory effect on gastric cancer cell SGC-7901 and esophageal cancer cell Eca-109, providing new Directions for the development of antibacterial drugs and anticancer drugs.
Smart Images

Figure CN118955672A_ABST
Abstract
Description
[Technical field]
[0001] The invention relates to the field of biotechnology, and in particular to Chinese horseshoe crab TaTrs_tachyplesinII_α2 antimicrobial peptide and a preparation method and application thereof. [Background technology]
[0003] Tachyplesins (TP-I, TP-II, TP-III) are located in the blood cells of the Chinese horseshoe crab granules. They are composed of 17 amino acid residues and have lipopolysaccharide binding activity. The mature protein has an antiparallel β-folded structure. The hydrophobic amino acids and positive charges are distributed on both sides of this special structure, which is considered to be closely related to antibacterial activity. At present, there are few studies on the Tachyplesins family proteins of Chinese horseshoe crabs. Antimicrobial peptides are a class of small molecule polypeptides with broad-spectrum antibacterial properties, usually composed of less than 100 amino acid residues, most of which are cationic, with cysteine stable structure and amphipathicity. The discovery and application of antibiotics are considered to be a great revolution in the development of human medicine. However, with the widespread use and even abuse of antibiotics in clinical, breeding and other industries in recent years, pathogenic microorganisms have been continuously evolved and acquired a wide range of drug resistance mechanisms to resist antibiotics. Antimicrobial peptides are a potential alternative to antibiotics because of their special mechanism of action and pattern diversity, which makes it difficult for microorganisms to develop drug resistance. They have broad prospects for the development of new peptide antibacterial drugs and can also be used as immune enhancers for farmed animals.
[0004] In the current research on antimicrobial peptides, we found that a class of antimicrobial peptides cannot inhibit the growth of all bacteria. Therefore, antimicrobial peptides need to be continuously verified to determine their applicable antibacterial range. At the same time, although antimicrobial peptides have been reported to have certain tumor cell inhibitory activity, functional verification has shown that antimicrobial peptides do not have inhibitory effects on all tumor cells. Therefore, in order to enhance the application field of antimicrobial peptides, it is necessary to perform functional verification and research on antimicrobial peptides, continuously verify their functional effects, and enrich the resource library. [Summary of the invention]
[0005] In view of the above, it is necessary to provide Chinese horseshoe crab TaTrs_tachyplesinII_α2 antimicrobial peptide and its preparation method and application, to develop an antimicrobial peptide that is effective against both aquatic pathogens and tumor cells, and to improve the application range of Chinese horseshoe crab antimicrobial peptide.
[0006] In order to achieve the above object, the technical solution adopted by the present invention is:
[0007] The Chinese horseshoe crab TaTrs_tachyplesinII_α2 antimicrobial peptide, the amino acid sequence of the Chinese horseshoe crab TaTrs_tachyplesinII_α2 antimicrobial peptide is shown in SEQ ID NO.3.
[0008] The present invention also includes the use of the Chinese horseshoe crab TaTrs_tachyplesinII_α2 antimicrobial peptide in the preparation of antimicrobial drugs.
[0009] Further, the bacteria inhibited by the antibacterial drug are Escherichia coli, Bacillus subtilis, Staphylococcus aureus, Corynebacterium glutamicum, Vibrio alginolyticus, Vibrio fluvialis, Micrococcus luteus, Shigella flexneri, Bacillus cereus, Vibrio harveyi, Aeromonas hydrophila and / or Pseudomonas stutzeri.
[0010] Furthermore, the minimum inhibitory concentration and minimum bactericidal concentration of the Chinese horseshoe crab TaTrs_tachyplesinII_α2 antimicrobial peptide to Shigella flexneri and Vibrio fluvialis are both 1.5-3 μM; the minimum inhibitory concentration and minimum bactericidal concentration to Vibrio alginolyticus and Aeromonas hydrophila are both 3-6 μM; the minimum inhibitory concentration and minimum bactericidal concentration to Vibrio harveyi and Staphylococcus aureus are both 3-6 μM and 6-12 μM; the minimum inhibitory concentration and minimum bactericidal concentration to Bacillus subtilis are 1.5-3 μM and 3-6 μM respectively; the minimum inhibitory concentration and minimum bactericidal concentration to Corynebacterium glutamicum are glutamicum) were both less than 1.5 μM.
[0011] The present invention also includes the use of the Chinese horseshoe crab TaTrs_tachyplesinII_α2 antimicrobial peptide in the preparation of anticancer drugs.
[0012] Furthermore, the cancer cells inhibited by the anticancer drug are gastric cancer cells and / or esophageal cancer cells.
[0013] Furthermore, the cancer cells inhibited by the anticancer drug are gastric cancer cells SGC-7901, and the esophageal cancer cells are Eca-109.
[0014] Furthermore, the concentration of the Chinese horseshoe crab TaTrs_tachyplesinII_α2 antimicrobial peptide as a drug for inhibiting gastric cancer cells SGC-7901 is greater than or equal to 80 μg / mL.
[0015] The present invention has the following beneficial effects:
[0016] 1. The present invention studies the horseshoe crab to develop a horseshoe crab antimicrobial peptide: TaTrs_tachyplesinII_α2. It has been verified that the antimicrobial peptide has good inhibitory effects on common pathogenic bacteria in aquaculture: Escherichia coli, Bacillus subtilis, Staphylococcus aureus, Corynebacterium glutamicum, Vibrio alginolyticus, Vibrio fluvialis, Micrococcus luteus, Shigella flexneri, Bacillus cereus, Vibrio harveyi, Aeromonas hydrophila and / or Pseudomonas stutzeri. At the same time, it also has a good inhibitory effect on the growth of gastric cancer cells SGC-7901 and / or esophageal cancer cells Eca-109. It can be widely used in the field of drug research and development and animal breeding immunoenhancers, and is a rare peptide product.
Brief Description of the Drawings
[0017] Figure 1 Diagram of the tertiary structure of a protein;
[0018] Figure 2 Antimicrobial peptides can form an amphipathic α-helical structure;
[0019] Figure 3 Photograph of a petri dish of Aeromonas hydrophila. [Specific implementation method]
[0020] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the specific embodiments of the present invention are described in detail below in conjunction with the accompanying drawings. In the following description, many specific details are set forth to facilitate a full understanding of the present invention. However, the present invention can be implemented in many other ways different from those described herein, and those skilled in the art can make similar improvements without violating the connotation of the present invention, so the present invention is not limited by the specific implementation disclosed below.
[0021] Embodiment 1:
[0022] 1. The specific method for obtaining the TaTrs_tachyplesinII antimicrobial peptide gene sequence of Chinese horseshoe crab is as follows:
[0023] Chinese horseshoe crab embryos and larvae were collected, total RNA was extracted, and transcriptome library sequencing was carried out after passing quality inspection. The trinity software was used to assemble the Chinese horseshoe crab reference transcripts. Finally, the blastp software was used to screen out a full-length cDNA sequence of the TaTrs_tachyplesinII antimicrobial peptide gene of Chinese horseshoe crab by homology alignment. The full-length cDNA sequence of the gene is shown in SEQ ID NO.1.
[0024] ATGAAGAAATTTGTAATTGCTTTGTGCCTGATGATGGTATTGGCTGTGATGGTGGAAGATGCCGAGGCTAGATGGTGCTTCAGAGTATGCTACAGGGGAATTTGTTATCGCAAATGTCGAGGGAAGAGGAATGAGGTGCGTCAGTACCGTGACCGTGGGTGTGATGTGGGAGCCATGCCAGATGAAACGTTCTTTGCACGACAGGACGAAGATGAAGATGACGATGAAGAGGAA.
[0025] The full-length cDNA of TaTrs_tachyplesinII antimicrobial peptide gene was translated into an amino acid sequence. The full-length amino acid sequence of TaTrs_tachyplesinII antimicrobial peptide is SEQ ID NO.2, which is as follows:
[0026] MKKFVIALCLMMVLAVMVEDAEARWCFRVCYRGICYRKCRGKRNEVRQYRDRGCDVGAMPDETFFARQDEDEDDDEEE
[0027] 2. Obtaining the tertiary protein structure of the mature peptide and the TaTrs_tachyplesinII polypeptide fragment with antibacterial activity:
[0028] SignalP-6.0 software was used to predict the signal peptide and mature peptide of TaTrs_tachyplesinII antimicrobial peptide, and the physicochemical properties and tertiary structure of the mature peptide were predicted using the websites https: / / web.expasy.org / protparam / and https: / / swissmodel.expasy.org / , respectively.
[0029] The results showed that the mature peptide consisted of 56 amino acids and its molecular formula was C 285 H 434 N 92 O 94S6, molecular weight is 6845.50 Daltons. The mature peptide has 12 positive charges and 15 negative charges, and is an anionic antimicrobial peptide. The tertiary structure of the protein is as follows Figure 1 As shown, it contains three α helices.
[0030] The website http: / / www.camp.bicnirrh.res.in / predict_c / was used to predict the polypeptide fragment with antibacterial activity of the mature peptide, and a polypeptide fragment with a length of 20 amino acids was obtained and named TaTrs_tachyplesinII_α2, and its amino acid sequence was SEQ ID NO.3; specifically: RWCFRVCYRGICYRKCRGKR.
[0031] The physicochemical properties and structural characteristics of TaTrs_tachyplesinII_α2 were predicted using the website https: / / heliquest.ipmc.cnrs.fr / cgi-bin / ComputParams.py.
[0032] The results showed that the antimicrobial peptide can form an amphipathic α-helical structure, such as Figure 2 As shown, it has obvious hydrophobic and hydrophilic surfaces and carries 8 positive charges. It is an α-helical cationic antimicrobial peptide.
[0033] 3. Preparation of TaTrs_tachyplesinII_α2 antimicrobial peptide from Chinese horseshoe crab:
[0034] The amino acid sequence of TaTrs_tachyplesinII_α2 antimicrobial peptide was submitted to Hubei Qiangyao Biotechnology Co., Ltd., and the company was commissioned to use solid phase chemical synthesis to synthesize the crude TaTrs_tachyplesinII_α2 antimicrobial peptide, which was then purified by high performance liquid chromatography and concentrated by a freeze dryer. Finally, a mass spectrometer was used to perform mass spectrometry identification. After qualified identification, high-purity TaTrs_tachyplesinII_α2 antimicrobial peptide was prepared.
[0035] 4. Determination of antimicrobial activity of TaTrs_tachyplesinII_α2 antimicrobial peptide from Chinese horseshoe crab:
[0036] In this example, Escherichia coli, Bacillus subtilis, Staphylococcus aureus, Corynebacterium glutamicum, Vibrio alginolyticus, Vibrio fluvialis, Micrococcus luteus, Shigella flexneri
[0037] Shigellaflexneri, Bacillus cereus, Vibrioharveyi, Aeromonas hydrophila and Pseudomonas stutzeri were used as test strains for antibacterial activity experiments. Among them, Escherichia coli, Staphylococcus aureus, Micrococcus luteus, Pseudomonas stutzeri and Aeromonas hydrophila were cultured in MHA medium at 28°C, and Corynebacterium glutamicum, Bacillus subtilis, Vibrio alginolyticus, Vibrio fluvii, Shigella flexneri, Bacillus cereus and Vibrio harveyi were cultured in 2216E medium at 37°C. All the strains used were purchased from the Marine Culture Collection of China (MCCC).
[0038] The method for determining the antimicrobial activity is as follows:
[0039] (1) Activation of refrigerated strains: Streak the bacterial strains (i.e., the above-mentioned test strains) stored at -80°C on MHA or 2216E plates, culture them at 28°C (marine bacteria) or 37°C (non-marine bacteria) for 24 h, pick a single colony and transfer it to 10 mL of sterile MHA or 2216E liquid culture medium, and culture it at 28°C or 37°C, shaking at 180 rpm / min for 12 h;
[0040] (2) Preparation of bacterial suspension: Take a small amount of activated bacterial liquid and streak it on MHA or 2216E plate, invert and culture for 12 h, pick a single colony from the plate and streak it on MHA or 2216E slant culture medium, culture it at 28°C or 37°C for 12 h, elute the slant culture with NaPB (10 mM), and measure the OD value of the eluate with a microplate reader. Add a certain amount of the eluate to NaPB or working culture medium so that the OD value of the final bacterial suspension is 0.0018;
[0041] (3) Preparation of antimicrobial peptide working solution: The antimicrobial peptide dry powder was dissolved in ultrapure water to prepare a working solution. After filtering through a 0.22 μm filter membrane, the protein concentration was determined by the Bradford method. The protein concentrations of the working solutions were diluted to 1.5, 3.0, 6.0, 12, 24, 48, and 96 μM and stored at 4°C for later use.
[0042] (4) Determination of minimum inhibitory concentration (MIC): Design an experimental group, a blank control group, and a negative control group for the experiment, with three parallels for each antimicrobial peptide concentration; culture the cells in a 96-well cell culture plate for 24 hours and observe the experimental results.
[0043] The reagents added to each group are as follows:
[0044] Experimental group: 50 μL antimicrobial peptide working solution + 50 μL bacterial suspension;
[0045] Blank control: 50 μL sterile water + 50 μL bacterial suspension;
[0046] Negative control: 50 μL working culture medium + 50 μL antimicrobial peptide working solution with the lowest concentration.
[0047] (5) Determination of minimum bactericidal concentration (MBC): Pipette 1 μL of the mixed culture from each well of the incubated cell culture plate and drop it onto an MHA or 2216E plate. Incubate for 24 h (the culture temperature for non-marine bacteria is 37°C and the culture temperature for marine bacteria is 28°C). Observe the colony formation.
[0048] The specific test results are shown in Table 1:
[0049] Table 1 Results of antibacterial activity determination of TaTrs_tachyplesinII_α2 antimicrobial peptide
[0050]
[0051] As can be seen from Table 1, the results show that TaTrs_tachyplesinII_α2 antimicrobial peptide has a strong inhibitory and killing effect on common pathogenic bacteria in aquaculture, and the inhibitory and killing effect on Micrococcus luteus is the most significant, with the minimum inhibitory concentration and the minimum bactericidal concentration both <1.5μM; it also has a strong inhibitory and killing effect on common foodborne pathogens in aquatic products, among which the minimum inhibitory concentration and the minimum bactericidal concentration for Shigella flexneri and Vibrio fluvialis are both 1.5-3μM, and the minimum inhibitory concentration and the minimum bactericidal concentration for Vibrio alginolyticus and Aeromonas hydrophila are 2. The minimum inhibitory concentration and minimum bactericidal concentration of bacteria are both 3-6μM, and the minimum inhibitory concentration and minimum bactericidal concentration for Vibrio harveyi and Staphylococcus aureus are 3-6μM and 6-12μM respectively; it has a significant effect on aquaculture probiotics Bacillus subtilis, with the minimum inhibitory concentration and minimum bactericidal concentration being 1.5-3μM and 3-6μM respectively; it has a strong inhibitory and killing effect on Corynebacterium glutamicum, an important bacterium in industrial and clinical applications, with the minimum inhibitory concentration and minimum bactericidal concentration both <1.5μM.
[0052] The plate culture of the killing test bacteria species takes Aeromonas hydrophila as an example. The photo of the culture dish of Aeromonas hydrophila is as follows: Figure 3 As shown in the figure, the plate was divided into 8 sector-shaped areas of equal size, and the concentrations of the antimicrobial peptide working solution in each area were 1.5 μM, 3.0 μM, 6.0 μM, 12 μM, 24 μM, 48 μM, 96 μM and 0.0 μM (blank culture medium group), wherein the blank culture medium group was not inoculated with Aeromonas hydrophila and did not use antimicrobial peptides; the concentrations of the antimicrobial peptide working solutions in different areas were marked with black text, from Figure 3 It can be seen that at a concentration of 1.5-3μM, Aeromonas hydrophila can grow on the plate, but at a concentration higher than 6μM, Aeromonas hydrophila cannot grow, which shows that the highest concentration of the antimicrobial peptide working solution that can grow Aeromonas hydrophila is 3μM, and the lowest concentration of the antimicrobial peptide working solution that kills Aeromonas hydrophila and cannot grow is 6μM. It can be concluded that the minimum bactericidal concentration of TaTrs_tachyplesinII_α2 antimicrobial peptide against Aeromonas hydrophila is 3-6μM.
[0053] Embodiment 2:
[0054] The applicant discovered that TaTrs_tachyplesinII_α2 antimicrobial peptide (hereinafter referred to as: α2 antimicrobial peptide) has a broad bactericidal effect and also has an inhibitory effect on the growth of cancer cells, as follows:
[0055] 1. Materials: SGC-7901 cells are derived from human gastric adenocarcinoma cell line, human esophageal carcinoma cell line Eca-109, and TaTrs_tachyplesinII_α2 antimicrobial peptide.
[0056] 2. Experimental method: The cell proliferation ability was detected by MTT assay. Under sterile conditions, 5×10 3 After 24 hours of culture, 10 μg / mL, 20 μg / mL, 40 μg / mL, 80 μg / mL and 160 μg / mL of α2 antimicrobial peptide were added to the wells respectively. The experimental group with only tumor cells was used as the blank group. After 1d, 2d, 3d, 4d, 5d, 6d and 7d of culture, 20 μL / well of freshly prepared MTT phosphate buffer was added respectively. After another 4h of culture, the culture medium in the plate was poured out, 150 μL of DMSO was added to each well, and the culture was shaken for 10 minutes. The absorbance (A value) of each well was measured at a wavelength of 570nm using an enzyme marker. The average value of A of 4 wells in each group was taken as the average A value of each group. The cell growth inhibition rate on the 6th day was calculated according to the following formula: IF (%) = (1-A of the drug group / A of the control group) × 100%. The results are shown in Table 2:
[0057] Table 2 Tumor cell growth inhibition rate after adding α2 antimicrobial peptide on the 6th day
[0058]
[0059] Note: Data in the same column with the same lowercase letters or no letters on shoulders indicate no significant difference (P>0.05), while data with different lowercase letters on shoulders indicate significant difference (P<0.05).
[0060] As can be seen from Table 2, α2 antimicrobial peptide has a significant inhibitory effect on both SGC-7901 cells and Eca-109 cells, and as the concentration increases, the inhibitory effect becomes better. The inhibition rate of SGC-7901 cells on the 6th day can reach up to 96.37%, and that of Eca-109 cells can reach up to 52.13%. From the inhibitory effect of the two cells: the inhibitory effect of α2 antimicrobial peptide on SGC-7901 cells is significantly better than that on Eca-109 cells, which shows that α2 antimicrobial peptide can inhibit the growth of tumor cells, but due to the difference in cells, the inhibitory effect on gastric cancer cells is better than that on esophageal cancer cells. From the inhibitory effect, when α2 antimicrobial peptide reaches 80 μg / mL, it can well inhibit the growth of SGC-7901 cells (the inhibition rate reaches more than 90%), which means that if it is used as a drug to inhibit the growth of SGC-7901 cells, the concentration can be selected to be above 80 μg / mL.
[0061] The TaTrs_tachyplesinII_α2 antimicrobial peptide of the present invention has been verified to have good antimicrobial function and is effective against most common pathogens in aquaculture. Cell experiments have also found that the antimicrobial peptide has a certain inhibitory effect on tumor cells, indicating that it has a certain anti-cancer function.
[0062] The above-described embodiments only express several implementation methods of the present invention, and the description thereof is relatively specific and detailed, but it cannot be understood as limiting the scope of the present invention. It should be pointed out that, for a person of ordinary skill in the art, several modifications and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the attached claims.
Claims
1. TaTrs_tachyplesinII_α2 antimicrobial peptide from Chinese horseshoe crab, characterized in that: The amino acid sequence of the Chinese horseshoe crab TaTrs_tachyplesinII_α2 antimicrobial peptide is shown in SEQ ID NO.
3.
2. Use of the Chinese horseshoe crab TaTrs_tachyplesinII_α2 antimicrobial peptide as claimed in claim 1 in the preparation of antibacterial drugs.
3. The use according to claim 2, characterized in that: The bacteria inhibited by the antibacterial drug are Escherichia coli, Bacillus subtilis, Staphylococcus aureus, Corynebacterium glutamicum, Vibrio alginolyticus, Vibrio fluvialis, Micrococcus luteus, Shigella flexneri, Bacillus cereus, Vibrio harveyi, Aeromonas hydrophila and / or Pseudomonas stutzeri.
4. The use according to claim 2, characterized in that: The minimum inhibitory concentration and minimum bactericidal concentration of the Chinese horseshoe crab TaTrs_tachyplesinII_α2 antimicrobial peptide to Shigella flexneri and Vibrio fluvialis are both 1.5-3 μM; the minimum inhibitory concentration and minimum bactericidal concentration to Vibrio alginolyticus and Aeromonas hydrophila are both 3-6 μM; the minimum inhibitory concentration and minimum bactericidal concentration to Vibrio harveyi and Staphylococcus aureus are both 3-6 μM and 6-12 μM; the minimum inhibitory concentration and minimum bactericidal concentration to Bacillus subtilis are 1.5-3 μM and 3-6 μM respectively; the minimum inhibitory concentration and minimum bactericidal concentration to Corynebacterium glutamicum are both <1.5 μM.
5. Use of the Chinese horseshoe crab TaTrs_tachyplesinII_α2 antimicrobial peptide as claimed in claim 1 in the preparation of anticancer drugs.
6. The use according to claim 5, characterized in that: The cancer cells inhibited by the anticancer drug are gastric cancer cells and / or esophageal cancer cells.
7. The use according to claim 6, characterized in that: The cancer cells inhibited by the anticancer drug are gastric cancer cells SGC-7901, and the esophageal cancer cells are Eca-109.
8. The use according to claim 5, characterized in that: The concentration of the Chinese horseshoe crab TaTrs_tachyplesinII_α2 antimicrobial peptide as a drug for inhibiting gastric cancer cells SGC-7901 is greater than or equal to 80 μg / mL.
Citation Information
Cited By
Antibacterial peptide mb217 and modified peptide and application thereof
CN120248041A
